AmerisourceBergen elects chairman
AmerisourceBergen taps Richard Gozon to replace James Mellor as chairman of its board of directors. The appointment is contingent on his re-election as a director during the company's Feb. 9, 2006 annual stockholders meeting. Mellor will retire at the meeting as required by the company's mandatory retirement provisions. A member of the board of directors since the company's creation in August 2001, Gozon previously served as director of AmeriSource Health Corp. for seven years and was exec VP of Weyerhaeuser Corp. from 1994 until his retirement in 2002...
You may also be interested in...
Taiwan’s JHL Biotech has rebranded itself as Eden Biologics at the same time as it has announced progress on clinical trials for its denosumab biosimilar candidate.
Starpharma's COVID-busting Viraleze antiviral nasal spray will soon be available across Europe, included the UK. But will it fall foul of local evidence requirements, for example in France, where the country's medicines agency has halted the sale of Pharma & Beauty (P&B) Group's COV-Defense spray until its efficacy against COVID has been confirmed by human-based studies?
Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization
A round up of COVID-19 developments, also including news on the EMA beginning a rolling review of Celltrion's antibody therapy, and progress for Novavax and Moderna in Japan.